ROHYPNOL

This brand name is authorized in Austria, Brazil, Germany, Hong Kong, Nigeria

Active ingredients

The drug ROHYPNOL contains one active pharmaceutical ingredient (API):

1 Flunitrazepam
UNII 620X0222FQ - FLUNITRAZEPAM

Flunitrazepam is a member of the benzodiazepine group of drugs and is closely related to nitrazepam, flurazepam and clonazepam. It has marked sedative and hypnotic properties with a rapid onset of action and is used in severe cases of insomnia.

Read about Flunitrazepam

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
N05CD03 Flunitrazepam N Nervous system → N05 Psycholeptics → N05C Hypnotics and sedatives → N05CD Benzodiazepine derivatives
Discover more medicines within N05CD03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: BR Câmara de Regulação do Mercado de Medicamentos Identifier(s): 509018020021818, 509018020021918, 529205401112314, 529205402119312
Country: DE Bundesinstitut für Arzneimittel und Medizinprodukte Identifier(s): 04846395
Country: HK Department of Health Drug Office Identifier(s): 12370
Country: NG Registered Drug Product Database Identifier(s): 04-0150

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.